E. Mallon

1.8k total citations
45 papers, 1.3k citations indexed

About

E. Mallon is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, E. Mallon has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cancer Research, 23 papers in Oncology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in E. Mallon's work include Breast Cancer Treatment Studies (26 papers), HER2/EGFR in Cancer Research (13 papers) and Breast Lesions and Carcinomas (10 papers). E. Mallon is often cited by papers focused on Breast Cancer Treatment Studies (26 papers), HER2/EGFR in Cancer Research (13 papers) and Breast Lesions and Carcinomas (10 papers). E. Mallon collaborates with scholars based in United Kingdom, United States and Netherlands. E. Mallon's co-authors include Ian O. Ellis, T Cooke, Mitch Dowsett, W.D. George, Arnie Purushotham, Joanne Edwards, B.A. Gusterson, R.D. Macmillan, WJ Gullick and R A Walker and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

E. Mallon

44 papers receiving 1.2k citations

Peers

Countries citing papers authored by E. Mallon

Since Specialization

Citations

This map shows the geographic impact of E. Mallon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Mallon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Mallon more than expected).

Fields of papers citing papers by E. Mallon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Mallon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Mallon. The network helps show where E. Mallon may publish in the future.

Co-authorship network of co-authors of E. Mallon

This figure shows the co-authorship network connecting the top 25 collaborators of E. Mallon. A scholar is included among the top collaborators of E. Mallon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Mallon. E. Mallon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ALSUntangled #74: Withania Somnifera (Ashwagandha) 2024 ·Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·(unknown), Paul E. Barkhaus, Andrew Brown, (unknown), Gregory T. Carter, (unknown), Terry Heiman‐Patterson, Xiaoyan Li, E. Mallon, Christopher McDermott, (unknown), Gary L. Pattee, (unknown), Paul Wicks, (unknown), Richard Bedlack	0
2	An International Multicenter Review of the Malignancy Rate of Excised Papillomatous Breast Lesions 2015 ·Annals of Surgical Oncology ·Niamh Foley, Jennifer M. Racz, Zahraa Al‐Hilli, Vicki Livingstone, Tulin Cil, Claire Holloway, László Romics, Zoltán Mátrai, Michael Bennett, (unknown), Sharon Nofech‐Mozes, Elzbieta Slodkowska, E. Mallon, (unknown), (unknown), (unknown), A Hill, H. P. Redmond, Mark Corrigan	26
3	Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial 2013 ·British Journal of Cancer ·John M.S. Bartlett, Cassandra Brookes, Tammy Piper, Cornelis J.�H. van de Velde, Deborah Stocken, (unknown), Annette Hasenburg, (unknown), D. G. Kieback, Hein Putter, Christos Markopoulos, (unknown), E. Mallon, Luc Dirix, Caroline Seynaeve, Daniel Rea	6
4	Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial 2013 ·European Journal of Cancer ·R.W. Blamey, T Bates, U Chetty, S W Duffy, Ian O. Ellis, David W. George, E. Mallon, M.J. Mitchell, I. Monypenny, D.A.L. Morgan, R. Douglas Macmillan, (unknown), Sarah E. Pinder	135
5	Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor-negative breast cancer 2012 ·British Journal of Cancer ·(unknown), Jaclyn S. Long, Clare Orange, Beatrix Elsberger, E. Mallon, Julie Doughty, Susan Pyne, Nigel J. Pyne, Joanne Edwards	59
6	Fibroelastoma of the mitral valve as a cause of embolic cerebral infarction 2011 ·BMJ Case Reports ·(unknown), James Walters, E. Mallon, (unknown)	2
7	Is there an association with phosphorylation and dephosphorylation of Src kinase at tyrosine 530 and breast cancer patient disease-specific survival 2010 ·British Journal of Cancer ·Beatrix Elsberger, (unknown), E. Mallon, Valerie G. Brunton, Joanne Edwards	9
8	Breast cancer patients’ clinical outcome measures are associated with Src kinase family member expression 2010 ·British Journal of Cancer ·Beatrix Elsberger, (unknown), Samer Zino, (unknown), Thomas J. Mitchell, Valerie G. Brunton, E. Mallon, Paul G. Shiels, Joanne Edwards	57
9	Poor Survival Outcomes in Elderly HER2 Positive Breast Cancer Patients. 2009 ·Cancer Research ·Sian Tovey, Joanne Edwards, (unknown), E. Mallon, (unknown)	1
10	Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer 2009 ·Annals of Oncology ·Giuseppe Viale, Anita Giobbie‐Hurder, B.A. Gusterson, Eugenio Maiorano, Mauro G. Mastropasqua, Angelica Sonzogni, E. Mallon, Marco Colleoni, Monica Castiglione‐Gertsch, Meredith M. Regan, Karen N. Price, Robert W. Brown, Rastko Golouh, Diana Crivellari, Per Karlsson, (unknown), Richard D. Gelber, Aron Goldhirsch, Alan S. Coates	23
11	Is the biology of breast cancer changing? A study of hormone receptor status 1984–1986 and 1996–1997 2009 ·British Journal of Cancer ·Sylvia Brown, E. Mallon, Joanne Edwards, Fiona Campbell, Liane M. McGlynn, Beatrix Elsberger, Timothy G. Cooke	18
12	Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER‐2 in 426 breast carcinomas from 37 centres 2003 ·The Journal of Pathology ·Mitch Dowsett, J. M. S. Bartlett, Ian O. Ellis, Janine Salter, Margaret Hills, E. Mallon, (unknown), T Cooke, Claire E. Paish, P.M. Wencyk, (unknown)	191
13	Adjuvant ovarian ablation vs CMF chemotherapy in premenopausal breast cancer patients: trial update and impact of immunohistochemical assessment of ER status 2002 ·The Breast ·C S Thomson, Chris Twelves, E. Mallon, Robin Leake	33
14	Optimum number of core biopsies for accurate assessment of histological grade in breast cancer 2002 ·British journal of surgery ·(unknown), Julie Doughty, W D George, E. Mallon	19
15	Ductal carcinoma in situ of the breast – among factors predicting for recurrence, distance from the nipple is important 2001 ·European Journal of Surgical Oncology ·Sheila Stallard, (unknown), Arnie Purushotham, (unknown), Hisham Mehanna, C. Cordiner, H. Dobson, E. Mallon, W D George	14
16	Assessment of HER2 status in breast cancer 2000 ·European Journal of Cancer ·Mitch Dowsett, T Cooke, Ian O. Ellis, WJ Gullick, B.A. Gusterson, E. Mallon, R A Walker	92
17	Margin assessment by cavity shaving after breast-conserving surgery: analysis and follow-up of 543 patients 1999 ·European Journal of Surgical Oncology ·Hafiz Malik, W.D. George, E. Mallon, A.N. Harnett, R.D. Macmillan, Arnie Purushotham	33
18	Tumour bed positivity predicts outcome after breast-conserving surgery. 1997 ·PubMed ·R.D. Macmillan, Arnie Purushotham, E. Mallon, J. Love, W.D. George	33
19	Hepatocyte growth factor/scatter factor expression and c-met in primary breast cancer 1996 ·Surgical Oncology ·János Nagy, (unknown), Kenneth J. Hillan, I C McKay, E. Mallon, Arnie Purushotham, W.D. George	46
20	Semiquantitative analyses of fine needle aspirates from benign and malignant breast lesions. 1989 ·Journal of Clinical Pathology ·Jeremy Thomas, E. Mallon, W.D. George	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact